Kyushu University Academic Staff Educational and Research Activities Database
List of Presentations
Shiota Masaki Last modified date:2024.04.09

Associate Professor / Department of Urology / Department of Clinical Medicine / Faculty of Medical Sciences


Presentations
1. Shiota Masaki, The utilization of the Japan Study Group of Prostate cancer registry data., Asian Pacific Prostate Society 2022, 2022.12.
2. Shiota M, Chikamatsu S, Blas L, Matsumoto T, Kashiwagi E, Inokuchi J, Shiga KI, Yokomizo A. Eto M, Prognostic significance of risk stratification in CHAARTED and LATITUDE studies among Japanese men with castration-resistant prostate cancer. , AUA 2022 Annual Meeting, 2022.05.
3. Shiota M, Ushijima M Matsumoto T, Kashiwagi E Inokuchi J, Eto M , An oral first-in-class small molecule RSK inhibitor suppresses AR variants and tumor growth in prostate cancer., AUA 2022 Annual Meeting, 2022.05.
4. Shiota M, Onozawa M, Hinotsu S, Eto M, Naito S, Akaza A; Japan Study Group of Prostate Cancer (J-CaP), Family history in primary hormone therapy for prostate cancer from a community-based multi-institutional Japan-wide database., 2019 ASCO 55nd Annual Meeting, 2019.06.
5. Shiota M, The role of oxidative stress in castration-resistant prostate cancer, and its diagnostic and therapeutic implications., 16th Urological Association of Asia Congress, 2019.06.
6. Shiota M, Fujimoto N, Imada K, Kashiwagi E, Takeuchi A, Inokuchi J, Tatsugami K, Kajioka S, Uchiumi T, Eto M, Independent validation of missense polymorphism in HSD3B1 in Japanese men treated with primary androgen-deprivation therapy for metastatic prostate cancer., 16th Urological Association of Asia Congress, 2018.04.
7. Shiota M, Fujimoto N, Imada K, Kashiwagi E, Takeuchi A, Inokuchi J, Tatsugami K, Kajioka S, Eto M, Missense polymorphism in HSD3B1 in Japanese men treated with primary androgen-deprivation therapy for metastatic prostate cancer., 2018 ASCO 54nd Annual Meeting, 2018.06.
8. Shiota M, JUA/AUA Joint Symposium
Panel Discussion (Prostate cancer), 第106回日本泌尿器科学会総会, 2018.04.
9. Shiota M, Yokomizo A,Takeuchi A, Kashiwagi E, Dejima T, Inokuchi J,Tatsugami K, Uchiumi T, Eto M, Protein kinase C regulates Twist1 expression via NF-κB
signaling in prostate cancer., 第76回日本癌学会学術総会, 2017.09.
10. Shiota M, Fujimoto N, Takeuchi A, Kashiwagi E, Dejima T, Inokuchi J, Tatsugami K, Yokomizo A, Uchiumi T, Eto M, The association of polymorphism in gonadotropin releasing hormone with serum testosterone level during androgen-deprivation therapy and prognosis in metastatic prostate cancer., 2017 ASCO 53nd Annual Meeting, 2017.06.
11. Shiota M, Kiyoshima K, Yokomizo A, Takeuchi A, Kashiwagi E, Takahashi R, Inokuchi J, Tatsugami K, Eto M, Suppressed recurrent bladder cancer after androgen suppression with androgen-deprivation therapy or 5α-reductase inhibitor., The 112th Annual Meeting AUA 2017, 2017.05.
12. Shiota M, Panel Discussion(RCC Cases)., 第105回日本泌尿器科学会総会, 2017.04.
13. 塩田 真己, The current trend of CRPC -the treatment strategy from biology and real world practice-., 第15回日本臨床腫瘍学会学術集会, 2017.07.
14. Masaki Shiota, Fujimoto N, Imada K, Yokomizo A, Ario Takeuchi, Kuruma H, Junichi Inokuchi, Tatsugami K, Uchiumi T, Oda Y, Naito S, Masatoshi Eto, Association of polymorphism in YB-1 regulating androgen receptor V7 expression with efficacy of androgen-deprivation therapy in metastatic prostate cancer., 2016 ASCO 52nd Annual Meeting, 2016.06.
15. Masaki Shiota, Masatoshi Eto, Genome-based precision medicine in the therapeutics for
prostate cancer., 第75回日本癌学会学術総会, 2016.10.
16. Masaki Shiota, Itsumi M, Ario Takeuchi, Imada K, Yokomizo A, Kuruma H, Junichi Inokuchi, Tatsugami K, Uchiumi T, Oda Y, Naito S, Masatoshi Eto, Crosstalk between epithelial-mesenchymal transition and castration resistance in prostate cancer., The 111th Annual Meeting AUA 2016, 2016.05.
17. Masaki Shiota, Yokomizo A, Ario Takeuchi, Imada K, Kiyoshima Keijiro, Junichi Inokuchi, Tatsugami K, Ohga S, Nakamura K, Honda H, Naito S, Masatoshi Eto, Secondary bladder cancer after anticancer therapy for prostate cancer: the effect of androgen-deprivation therapy and smoking., 第104回日本泌尿器科学会総会, 2016.04.
18. Shiota M, Itsumi M, Yokomizo A, Takeuchi A, Imada K, Kashiwagi E, Inokuchi J, Tatsugami K, Uchiumi T, Naito S, Targeting ribosomal S6 kinases/Y-box binding protein-1 signaling improves cellular sensitivity to taxane in prostate cancer., The 110th Annual Meeting AUA 2015, 2015.05.